Accountable care organizations (ACOs) are of 2 minds right now. On the one hand, there is a lot of excitement for the future of ACOs, but there is also great anxiety around the changes that CMS proposed for the Medicare Shared Savings Program (MSSP), said Clif Gaus, ScD, president and CEO of the National Association of ACOs (NAACOS).
Accountable care organizations (ACOs) are of 2 minds right now. On the one hand, there is a lot of excitement for the future of ACOs, but there is also great anxiety around the changes that CMS proposed for the Medicare Shared Savings Program (MSSP), said Clif Gaus, ScD, president and CEO of the National Association of ACOs (NAACOS).
Transcript
What were some of the key takeaways from the NAACOS fall 2018 meeting?
I would say there are a couple, in addition to breaking our own record with attendance, and I would say the level of excitement here is as high as I’ve seen around our future, but the anxiety is probably as high as I’ve ever seen because of the proposed changes that CMS is proposed to make [to MSSP].
I’m confident, I guess, that we’ll see some give on their part, particularly around the speed that they’re asking us to move to risk, and particularly around the reduction in shared savings. I’m quoted in other places as saying, “there’s a carrot and a stick, and what they proposed to do is cut the carrot in half.” And going from 50% savings shared with the ACO to 25% is a dramatic decline and that would affect the new ACOs coming into the program in 2019 and 2020.
So, we’re hopeful they’ll both adjust that speed to risk and the shared savings amount—go back to the 50%. We see that as a minimum to engage the hospitals and doctors in what is an expensive undertaking for them. Our estimates are at least $1 million a year in infrastructure for an ACO, on average, and that includes hiring the care coordinators, that includes all the information systems, and medical systems. So, they’re not going to make that kind of investment out of their own pockets, if there’s not some hope that they’ll achieve savings and get paid back for that.
The Supreme Court seems likely to reject a challenge to the abortion pill mifepristone; the FDA is inspecting far fewer pharmaceutical companies conducting clinical research; AstraZeneca has sued to block an Arkansas law that it said would unlawfully expand the 340B program to include for profit-pharmacy chains.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Dupilumab Considered Safe, Effective Treatment for Adolescent, Adult Patients With AD
March 20th 2024These posters both used the GLOBOSTAD study, which demonstrated through patient and physician assessments that dupilumab is a safe and effective treatment for adolescent and adult patients with atopic dermatitis (AD).
Read More
Covered Preventive Services at Risk: V-BID Summit Breaks Down the Braidwood v Becerra Case
March 20th 2024For more than a decade, certain high-value preventive care services have been covered at no cost to patients under the Affordable Care Act, but a current legal challenge has the coverage at risk.
Read More